Literature DB >> 6132696

Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

J Feely.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6132696     DOI： 10.2165/00003088-198308010-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  73 in total

1.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

2.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

3.  Proceedings: Changes in drug metabolizing ability in thyroid disease.

Authors:  J Crooks; A J Hedley; C Macnee; I H Stevenson
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

Review 4.  Thyroid hormone and the kidney.

Authors:  A I Katz; D S Emmanouel; M D Lindheimer
Journal:  Nephron       Date:  1975       Impact factor: 2.847

5.  Thyroid hormone regulation of beta-adrenergic receptor number.

Authors:  L T Williams; R J Lefkowitz; A M Watanabe; D R Hathaway; H R Besch
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

Review 6.  Drug metabolism in thyroid disease.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.

Authors:  O R Nilsson; A Melander; L Tegler
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

8.  Influence of surgery on plasma propranolol levels and protein binding.

Authors:  J Feely; A Forrest; A Gunn; W Hamilton; I Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

9.  Propranolol dynamics in thyrotoxicosis.

Authors:  J Feely; I H Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

10.  Plasma propranolol steady state concentrations in thyroid disorders.

Authors:  J Feely; J Crooks; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
View more
  5 in total

Review 1.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

2.  Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.

Authors:  S Klug; R Thiel; R Schwabe; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 3.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 4.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

5.  Evolution of atenolol kinetics when hypothyroidism is corrected.

Authors:  H Levesque; M O Richard; J Fresel; A Gancel; N Moore; H Courtois
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.